Skip to content
Human umbilical artery endothelial cells (HUAEC)
Tissue
Umbilical cord (artery)
Disease
Normal umbilical artery endothelium (primary cells; non-tumorigenic; neonatal)
Metastatic site
Not applicable (normal, non-tumorigenic primary cell)
Synonyms
HUAEC, Human umbilical artery endothelial cells, provitro 1210112

Documents

Human umbilical artery endothelial cells (HUAEC)

Primary cell · Product number 300698

The arterial counterpart to HUVEC

€910.00excl. tax and shipping

Customization / Recommendations

Made to order
1

01General information

Description

Primary Human Umbilical Artery Endothelial Cells (HUAEC) are isolated from the umbilical artery and provide an arterial counterpart to HUVEC. They are used to study arterial–venous differences in inflammation, nitric oxide signaling and fetal programming in pregnancy-related disorders.

Compared directly with HUVEC, HUAEC respond to inflammatory stimuli such as TNF-α with a distinct pattern of gene regulation, including differences in how they return to homeostasis after the stimulus is removed. This makes them well suited to test whether findings in venous endothelium also hold for arterial endothelium.

Tissue
Umbilical cord (artery)
Disease
Normal umbilical artery endothelium (primary cells; non-tumorigenic; neonatal)
Metastatic site
Not applicable (normal, non-tumorigenic primary cell)
Applications
Arterial–venous differences in inflammation and its resolution; Fetal programming: maternal obesity, oxidative stress and epigenetics; Nitric oxide, eNOS and arginase-2 regulation, epigenetic pharmacology; Angiogenesis assays (Matrigel tube formation, migration); Anti-proliferative screening of angiogenesis inhibitors (VEGF receptor 2)
Synonyms
  • HUAEC
  • Human umbilical artery endothelial cells
  • provitro 1210112

02Donor

Donor age
Newborn (umbilical cord)
Ethnicity
Lot-specific (see CoA)

03Classification

Organism
Human
Sex
Lot-specific
Growth properties
Adherent
GMO status
Non-GMO
GMO status details
No genetic modification; primary human endothelial cells isolated from umbilical artery. Not transformed or immortalized. Tested and confirmed negative for mycoplasma, bacteria, yeast, HIV-1/2, HBV, HCV.
Biosafety level
1

04Characteristics

Morphology
Cobblestone (endothelial)
Cell type
Primary endothelial cells
Tumourigenic
No
Doubling time
approx. 24 to 36 hours (lot-specific; guaranteed ≥15 population doublings under ScienCell-recommended conditions)

05Handling and culture

Culture medium
Endothelial Cell Growth Medium
Incubation atmosphere

37°C, 5% CO2, saturated humidity.

Supplements
ScienCell ECM #1001 is pre-supplemented with FBS, endothelial cell growth supplement (ECGS), and antibiotics as specified in the medium kit; no additional serum supplement needed. Coat culture vessels with fibronectin (1–2 µg/cm²) before seeding.
Dissociation reagent
Subculture reagents as recommended on the certificate of analysis
Flask coating
Fibronectin coating required (1–2 µg/cm²; incubate at 37°C for 30 min, aspirate excess before seeding)
Subculturing

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Split ratio
1 to 3
Seeding density
More than 6,000 cells/cm²
Fluid renewal
24 hours after seeding, then every 48 to 72 hours
Post-thaw recovery

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Thawing and culturing
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Freeze medium
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Storage conditions

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Shipping conditions

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Expression and susceptibility

Surface antigens
CD31 (PECAM-1) +; vWF (Factor VIII) +; Dil-Ac-LDL uptake +; Ephrin-B2 + (arterial marker); DLL4 + (arterial marker); Notch4 + (arterial marker); NRP1 + (arterial marker)
Receptors expressed
VEGFR2 (KDR); VEGFR1 (Flt1); TIE-2; NRP1 (arterial-specific); Notch receptor (Notch1, Notch4)
Viruses
Free of HIV-1, HIV-2, HBV, HCV (confirmed negative; ScienCell #8010 QC)

08Identifiers

Citation
Human umbilical artery endothelial cells (HUAEC) (Cytion catalog number 300698)
NCBI TaxID
9606
Cellosaurus
Not assigned